Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal immune system is a complex network of cells, molecules, and structures that protect the gastrointestinal tract from pathogens and harmful antigens while maintaining tolerance to commensal microbiota and dietary antigens. Its key components include physical barriers (epithelial cells, mucus layer), chemical barriers (antimicrobial peptides, SIgA), immune cells (innate and adaptive), GALT, and the microbiome. Dysfunction can lead to increased intestinal permeability, chronic inflammation, and autoimmune diseases. Restoring and maintaining mucosal barrier integrity is crucial for preventing these disorders.
Modulation of immune cell activity, enhancement of barrier function, alteration of microbiota composition
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Mucosal Immune System (IMIS).